Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Non-Current Debt: 2011-2024

Historic Non-Current Debt for Mimedx Group (MDXG) over the last 7 years, with Dec 2024 value amounting to $17.8 million.

  • Mimedx Group's Non-Current Debt fell 6.54% to $16.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.8 million, marking a year-over-year decrease of 6.54%. This contributed to the annual value of $17.8 million for FY2024, which is 62.93% down from last year.
  • As of FY2024, Mimedx Group's Non-Current Debt stood at $17.8 million, which was down 62.93% from $48.1 million recorded in FY2023.
  • In the past 5 years, Mimedx Group's Non-Current Debt ranged from a high of $48.6 million in FY2022 and a low of $17.8 million during FY2024.
  • Over the past 3 years, Mimedx Group's median Non-Current Debt value was $48.1 million (recorded in 2023), while the average stood at $38.2 million.
  • Its Non-Current Debt has fluctuated over the past 5 years, first increased by 0.97% in 2022, then tumbled by 62.93% in 2024.
  • Mimedx Group's Non-Current Debt (Yearly) stood at $47.7 million in 2020, then rose by 0.90% to $48.1 million in 2021, then grew by 0.97% to $48.6 million in 2022, then declined by 1.02% to $48.1 million in 2023, then crashed by 62.93% to $17.8 million in 2024.